Mariam E. Morris
2018
In 2018, Mariam E. Morris earned a total compensation of $687.5K as Former Chief Financial Officer at Avalo Therapeutics, a 116% increase compared to previous year.
Compensation breakdown
| Option Awards | $186,868 |
|---|---|
| Salary | $164,767 |
| Other | $335,833 |
| Total | $687,468 |
Morris received $335.8K in other compensation, accounting for 49% of the total pay in 2018.
Morris also received $186.9K in option awards and $164.8K in salary.
Rankings
In 2018, Mariam E. Morris' compensation ranked 10,793rd out of 14,244 executives tracked by ExecPay. In other words, Morris earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,793 out of 14,244 | 24th |
Division Manufacturing | 4,346 out of 5,759 | 25th |
Major group Chemicals And Allied Products | 1,638 out of 2,122 | 23rd |
Industry group Drugs | 1,387 out of 1,811 | 23rd |
Industry Pharmaceutical Preparations | 1,064 out of 1,385 | 23rd |
Source: SEC filing on June 19, 2019.
Morris' colleagues
We found six more compensation records of executives who worked with Mariam E. Morris at Avalo Therapeutics in 2018.
2018
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2018
Joseph Miller
Avalo Therapeutics
Chief Financial Officer
2018
James Harrell
Avalo Therapeutics
Executive Vice President, Marketing and External Communications
2018
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
2018
Robert Moscato
Avalo Therapeutics
Chief Operating Officer
2018
Simon Pedder
Avalo Therapeutics